Proteome-wide Mendelian randomization identifies therapeutic targets for ankylosing spondylitis

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1Succinate metabolism: a promising therapeutic target for inflammation, ischemia/reperfusion injury and cancer2023 · 80 citations
2. 2Treg Enhancing Therapies to Treat Autoimmune Diseases2020 · 251 citations
3. 3Metabolism of Tacrolimus (FK506) and Recent Topics in Clinical Pharmacokinetics2007 · 261 citations
4. 4Polymorphisms −374 T/A and −429 T/C of the Receptor for Advanced Glycation End-Products (RAGE) and Serum Levels of RAGE (sRAGE) Are Not Associated with Metabolic Syndrome2023 · 7 citations
5. 5Comprehensive epigenomic profiling reveals the extent of disease-specific chromatin states and informs target discovery in ankylosing spondylitis2023 · 29 citations